Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine

Lancet Oncol. 2006 Oct;7(10):877-9. doi: 10.1016/S1470-2045(06)70908-1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Papillary / metabolism
  • Carcinoma, Papillary / pathology
  • Carcinoma, Papillary / therapy*
  • Cell Differentiation / drug effects*
  • Cells, Cultured
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Iodine Radioisotopes / pharmacokinetics
  • Iodine Radioisotopes / therapeutic use
  • Nevirapine / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Thyroglobulin / analysis
  • Thyroid Gland / cytology
  • Thyroid Gland / drug effects
  • Thyroid Gland / metabolism
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / therapy*
  • Thyroidectomy
  • Tumor Cells, Cultured

Substances

  • Iodine Radioisotopes
  • Reverse Transcriptase Inhibitors
  • Thyroglobulin
  • Nevirapine